Home › NDC Lookup › RxCUI directory › RxCUI 260847

Aspirin 325 MG Oral Tablet [Bufferin] — RxCUI 260847

RxNorm drug concept · Semantic branded drug
RxCUI 260847 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI260847
Official nameAspirin 325 MG Oral Tablet [Bufferin]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asBufferin 325 MG Oral Tablet; ASA 325 MG Oral Tablet [Bufferin]
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Aspirin Rectal: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Take it out of its plastic packet and insert it into the rectum as far as possible. Adults usually use one every 4 hours, for no more than 10 days, or as your physician directs.
  • Children under 12 should only use it after talking to a physician. Children and teenagers who have or are recovering from chicken pox, flu symptoms, or flu should not use it at all...
  • Aspirin has been linked to Reye syndrome, a rare but serious illness. If nausea, vomiting, or fever occur, talk to a doctor right away.
  • Check with a health professional first if you are pregnant or nursing. It is especially important not to use aspirin in the last 3 months of pregnancy unless your doctor directs it...
📖 Read our full Aspirin Rectal guide →

🕸️ Concept Web — How Aspirin 325 MG Oral Tablet [Bufferin] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Aspirin 325 MG Oral Tablet [Bufferin] RxCUI 260847

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Aspirin 1191
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Bufferin 215770
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Aspirin Oral Tablet 370611
    • Aspirin Oral Product 1154069
    • Aspirin Pill 1154070
    • Aspirin Oral Tablet [Bufferin] 368653
    • Bufferin Oral Product 1168674
    • Bufferin Pill 1168675
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

  5. Packs 1

    Fixed collections of drugs packaged and sold together, like dose packs.

    • {30 (aspirin 325 MG Oral Tablet) / 30 (pravastatin sodium 80 MG Oral Tablet) } Pack 904664

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Aspirin 325 MG Oral Tablet SCD · 212033
  • Aspirin 325 MG SCDC · 317300
  • Aspirin Oral Tablet SCDF · 370611
  • Aspirin Oral Product SCDG · 1154069
  • Aspirin Pill SCDG · 1154070
  • {30 (aspirin 325 MG Oral Tablet) / 30 (pravastatin sodium 80 MG Oral Tablet) } Pack GPCK · 904664

Brand-Name Concepts

  • Aspirin 325 MG [Bufferin] SBDC · 574308
  • Aspirin Oral Tablet [Bufferin] SBDF · 368653
  • Bufferin Oral Product SBDG · 1168674
  • Bufferin Pill SBDG · 1168675
  • Bufferin BN · 215770

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 260847 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
50066-0610-13 1 BOTTLE, PLASTIC in 1 CARTON (50066-610-13) / 130 TABLET,... Bufferin Regular Strength Pain Relief Genomma Lab USA 2021-05-17
Observed labelers: Genomma Lab USA (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.